Liquidia Corporation (NASDAQ:LQDA - Get Free Report) Director Katherine Rielly-Gauvin sold 18,393 shares of Liquidia stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $72.23, for a total value of $1,328,526.39. Following the completion of the transaction, the director directly owned 44,637 shares in the company, valued at $3,224,130.51. This represents a 29.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Katherine Rielly-Gauvin also recently made the following trade(s):
- On Wednesday, August 19th, Katherine Rielly-Gauvin sold 36,789 shares of Liquidia stock. The stock was sold at an average price of $74.99, for a total transaction of $2,758,807.11.
Liquidia Trading Down 3.4%
NASDAQ LQDA traded down $2.43 during mid-day trading on Friday, hitting $68.62. The company's stock had a trading volume of 1,698,657 shares, compared to its average volume of 1,793,328. Liquidia Corporation has a 52-week low of $21.15 and a 52-week high of $93.61. The stock's fifty day simple moving average is $79.34 and its two-hundred day simple moving average is $56.13. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The firm has a market capitalization of $6.14 billion, a P/E ratio of 50.09 and a beta of 0.58.
Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts' consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business had revenue of $171.68 million for the quarter, compared to analyst estimates of $168.48 million. During the same period last year, the firm earned ($0.49) earnings per share. The company's quarterly revenue was up 1842.1% on a year-over-year basis. Research analysts expect that Liquidia Corporation will post 2.57 EPS for the current year.
Analysts Set New Price Targets
LQDA has been the subject of a number of research reports. Zacks Research cut shares of Liquidia from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 13th. Piper Sandler set a $129.00 price objective on Liquidia in a research report on Friday, July 24th. Wells Fargo & Company raised their price objective on Liquidia from $62.00 to $108.00 and gave the company an "overweight" rating in a research report on Thursday, August 13th. Bank of America boosted their price objective on Liquidia from $79.00 to $92.00 and gave the stock a "neutral" rating in a research note on Thursday, August 13th. Finally, Wall Street Zen downgraded Liquidia from a "strong-buy" rating to a "buy" rating in a research report on Saturday, June 27th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Liquidia currently has a consensus rating of "Hold" and an average target price of $98.08.
Check Out Our Latest Stock Report on LQDA
Hedge Funds Weigh In On Liquidia
Several institutional investors and hedge funds have recently made changes to their positions in the business. GSA Capital Partners LLP grew its position in shares of Liquidia by 63.6% during the fourth quarter. GSA Capital Partners LLP now owns 63,176 shares of the company's stock worth $2,179,000 after buying an additional 24,555 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in Liquidia by 63.3% in the first quarter. The Manufacturers Life Insurance Company now owns 58,265 shares of the company's stock valued at $2,199,000 after acquiring an additional 22,592 shares in the last quarter. State of New Jersey Common Pension Fund D bought a new position in Liquidia during the 4th quarter valued at $709,000. WCG Wealth Advisors LLC boosted its stake in Liquidia by 98.2% during the 4th quarter. WCG Wealth Advisors LLC now owns 54,411 shares of the company's stock valued at $1,877,000 after acquiring an additional 26,957 shares during the last quarter. Finally, Handelsbanken Fonder AB acquired a new position in Liquidia during the 2nd quarter worth $1,993,000. 64.54% of the stock is currently owned by hedge funds and other institutional investors.
About Liquidia
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Liquidia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.
While Liquidia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.